Satyanarayana Medicherla

Biochemistry, Genetics and Molecular Biology · Life Sciences

23h-index1.9kcitations34works0.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Melanoma and MAPK Pathways(9), Multiple Myeloma Research and Treatments(5), Cholesterol and Lipid Metabolism(5), Estrogen and related hormone effects(4), Pancreatic function and diabetes(4)

Publications34 total

Role of the androgen receptor in breast cancer and preclinical analysis of enzalutamide
Breast Cancer Research·2014· 391 citedOpen Access
P38α-Selective Mitogen-Activated Protein Kinase Inhibitor for Improvement of Cultured Human Islet Recovery
Pancreas·2010· 12 cited
Corrigendum to “Role of p38 mitogen-activated protein kinase in ozone-induced airway hyperresponsiveness and inflammation” [European Journal of Pharmacology 600 (2008) 117-122]
European Journal of Pharmacology·2009· 1 cited
p38alpha-selective MAP kinase inhibitor reduces tumor growth in mouse xenograft models of multiple myeloma.
PubMed·2009· 23 cited
Analgesic effects of p38 kinase inhibitor treatment on bone fracture healing
Pain·2009· 23 cited
Role of p38 mitogen-activated protein kinase in ozone-induced airway hyperresponsiveness and inflammation
European Journal of Pharmacology·2008· 38 cited
Transforming Growth Factor-β Blockade Down-Regulates the Renin-Angiotensin System and Modifies Cardiac Remodeling after Myocardial Infarction
Endocrinology·2008· 67 cited
Role of p38 mitogen activated protein kinase in a model of osteosarcoma-induced pain
Pharmacology Biochemistry and Behavior·2008· 26 cited
Inhibition of the TGF-β receptor I kinase promotes hematopoiesis in MDS
Blood·2008· 175 citedOpen Access
Antitumor activity of TGF-beta inhibitor is dependent on the microenvironment.
PubMed·2008· 61 cited
Pharmacological Properties of SD-282 – An α-Isoform Selective Inhibitor for p38 MAP Kinase
Pharmacology·2008· 10 cited
p38α-Selective Mitogen-Activated Protein Kinase Inhibitor SD-282 Reduces Inflammation in a Subchronic Model of Tobacco Smoke-Induced Airway Inflammation
Journal of Pharmacology and Experimental Therapeutics·2007· 94 cited
A p38 Mitogen‐Activated Protein Kinase Inhibitor Arrests Active Alveolar Bone Loss in a Rat Periodontitis Model
Journal of Periodontology·2007· 56 citedOpen Access
Inhibition of Transforming Growth Factor β Signaling Reduces Pancreatic Adenocarcinoma Growth and Invasiveness
Molecular Pharmacology·2007· 118 cited
Improvement of Human Islet Cryopreservation by a p38 MAPK Inhibitor
American Journal of Transplantation·2007· 34 citedOpen Access
Inhibition of p38alpha MAPK prevents the development of osteolytic bone disease, reduces tumor burden and increases survival in murine models of Multiple Myeloma
VUBIR (Vrije Universiteit Brussel)·2007
A p38α Selective Mitogen-Activated Protein Kinase Inhibitor Prevents Periodontal Bone Loss
Journal of Pharmacology and Experimental Therapeutics·2006· 67 cited
LDL and cAMP cooperate to regulate the functional expression of the LRP in rat ovarian granulosa cells
Journal of Lipid Research·2006· 8 citedOpen Access
Effect of Transforming Growth Factor-β Receptor I Kinase Inhibitor 2,4-Disubstituted Pteridine (SD-208) in Chronic Allergic Airway Inflammation and Remodeling
Journal of Pharmacology and Experimental Therapeutics·2006· 62 cited
Importance of p38 mitogen-activated protein kinase pathway in allergic airway remodelling and bronchial hyperresponsiveness
European Journal of Pharmacology·2006· 54 cited
page 1 of 2Next →

Frequent Co-authors

Linda S. Higgins(17), Andrew A. Protter(14), Ann M. Kapoun(10), Sarvajit Chakravarty(9), Sundeep Dugar(9), Tony Navas(6), George F. Schreiner(6), Ying Jing(5), Gilbert O’Young(5), Eve Reaven(5), Irene Kerr(5), Aaron Nguyen(4), Mamatha Reddy(4), Salman Azhar(4), Gregory R. Luedtke(4), Andy Protter(4), Ruban Mangadu(4), Ramona G. Almirez(4), Alison S. Williams(4), Kian Fan Chung(4)